4 completed. 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 4 |
Follow QPX7728: new trials by email Literature Review of QPX7728 trials Research Report on QPX7728
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Investigate Safety and Pharmacokinetics of Intravenous Cefiderocol/Xeruborbactam in Participants With Renal Impairment Cefiderocol/Xeruborbactam - Bacterial Infections | Phase 1 | Completed | Qpex Biopharma, Inc. | 40 | 2025-09-16 | 2026-09-25 |
| A DDI Study to Investigate PK and Safety of Cefiderocol in Combination With Xeruborbactam in Healthy Adult Participants Xeruborbactam, Cefiderocol, Xeruborbactam/Cefiderocol - Bacterial Infections | Phase 1 | Completed | Qpex Biopharma, Inc. | 60 | 2024-09-04 | 2025-11-28 |
| Drug-Drug Interaction Study of IV QPX2014 Combined With QPX7728 in Healthy Adult Subjects QPX7728, QPX2014 - Bacterial Infections | Phase 1 | Completed | Qpex Biopharma, Inc. | 12 | 2021-11-15 | 2022-10-10 |
| P1 Single and Multiple Ascending Dose (SAD/MAD) Study of IV QPX7728 Alone and Combined With QPX2014 in NHV QPX7728, Placebo, QPX2014 - Bacterial Infections | Phase 1 | Completed | Qpex Biopharma, Inc. | 82 | 2020-11-24 | 2022-10-10 |
United States (4) · Australia (1)
Jeff S Loutit, MBChB (1) · Jeffery S Loutit, MBChB (1) · Richard Preston, MD (1) · Thomas Marbury, MD (1)